SF Healthcare Week: Beam's CEO John Evans shares an update on based editing for alpha-1 antitrypsin deficiency, sickle cell disease, and more
BiotechTV - News
00:00
Outro
Episode wrap-up and goodbyes from Amy and John.
Play episode from 10:18
Transcript
